Syndax Pharmaceuticals Inc Income Tax Expense (Benefit) in USD from Q1 2015 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Syndax Pharmaceuticals Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2015 to Q1 2025.
  • Syndax Pharmaceuticals Inc Income Tax Expense (Benefit) for the quarter ending March 31, 2025 was $0.000.
  • Syndax Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2021 was $0.000.
  • Syndax Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2020 was $0.000.
  • Syndax Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2019 was $0.000.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), Annual (USD)

Syndax Pharmaceuticals Inc Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $0 $0 Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-05
Q1 2024 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-05
Q1 2018 $0 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-09
Q1 2017 $0 $0 Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q1 2016 $0 $0 Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q1 2015 $0 Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16

Syndax Pharmaceuticals Inc Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $0 $0 Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 $0 $0 Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $0 $0 Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 $0 $0 Jan 1, 2018 Dec 31, 2018 10-K 2020-03-05
2017 $0 $0 Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2016 $0 $0 Jan 1, 2016 Dec 31, 2016 10-K 2018-03-08
2015 $0 Jan 1, 2015 Dec 31, 2015 10-K 2017-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.